Direct Molecular Characterization of Bacteria From ICU and From the REHAB

NCT03475472 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 971

Last updated 2021-02-17

No results posted yet for this study

Summary

Investigators aim to directly investigate the molecular properties of bacteria from tracheal and urinary samples routinely taken in intensive care units (ICU) patients.

Conditions

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Nina Khanna, Prof. Dr. MD · University Hospital, Basel, Switzerland

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2021-01-27
Completion
2021-01-27

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03475472 on ClinicalTrials.gov